|
1
|
Louis DN, Perry A, Reifenberger G, von
Deimling A, Figarella-Branger D, Cavenee WK, Ohgaki H, Wiestler OD,
Kleihues P and Ellison DW: The 2016 World Health Organization
classification of tumors of the central nervous system: A summary.
Acta Neuropathol. 131:803–820. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Velikova G, Coens C, Efficace F, Greimel
E, Groenvold M, Johnson C, Singer S, van de Poll-Franse L, Young T
and Bottomley A: Health-related quality of life in EORTC clinical
trials-30 years of progress from methodological developments to
making a real impact on oncology practice. EJC Suppl. 10:141–149.
2012. View Article : Google Scholar
|
|
3
|
Outcomes of cancer treatment for
technology assessment and cancer treatment guidelines. American
Society of Clinical Oncology. J Clin Oncol. 14:671–679. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Jocham HR, Dassen T, Widdershoven G and
Halfens R: Quality of life in palliative care cancer patients: A
literature review. J Clin Nurs. 15:1188–1195. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Steinmann D, Vordermark D, Geinitz H,
Aschoff R, Bayerl A, Gerstein J, Hipp M, van Oorschot B, Wypior HJ
and Schäfer C: Proxy assessment of patients before and after
radiotherapy for brain metastases. Results of a prospective study
using the DEGRO brain module. Strahlenther Onkol. 189:47–53. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Velikova G, Booth L, Smith AB, Brown PM,
Lynch P, Brown JM and Selby PJ: Measuring quality of life in
routine oncology practice improves communication and patient
well-being: A randomized controlled trial. J Clin Oncol.
22:714–724. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Quinten C, Maringwa J, Gotay CC,
Martinelli F, Coens C, Reeve BB, Flechtner H, Greimel E, King M,
Osoba D, et al: Patient self-reports of symptoms and clinician
ratings as predictors of overall cancer survival. J Natl Cancer
Inst. 103:1851–1858. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Aaronson NK, Ahmedzai S, Bergman B,
Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman
SB, de Haes JC, et al: The European organization for research and
treatment of cancer QLQ-C30: A quality-of-life instrument for use
in international clinical trials in oncology. J Natl Cancer Inst.
85:365–376. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chow R, Lao N, Popovic M, Chow E, Cella D,
Beaumont J, Lam H, Pulenzas N, Bedard G, Wong E, et al: Comparison
of the EORTC QLQ-BN20 and the FACT-Br quality of life
questionnaires for patients with primary brain cancers: A
literature review. Support Care Cancer. 22:2593–2598. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Taphoorn MJ, Claassens L, Aaronson NK,
Coens C, Mauer M, Osoba D, Stupp R, Mirimanoff RO, van den Bent MJ
and Bottomley A; EORTC Quality of Life Group, and Brain Cancer,
NCIC and Radiotherapy Groups, : An international validation study
of the EORTC brain cancer module (EORTC QLQ-BN20) for assessing
health-related quality of life and symptoms in brain cancer
patients. Eur J Cancer. 46:1033–1040. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Fayers PM, Aaronson NK, Bjordal K,
Groenvold M, Curran D and Bottomley A; The EORTC Quality of Life
Group, : The EORTC QLQ-C30 Scoring Manual. 3rd. European
Organisation for Research and Treatment of Cancer; Brussels:
2001
|
|
12
|
Cancer Therapy Evaluation Program: Common
Terminology Criteria for Adverse Events, Version 3.0. DCTD, NCI,
NIH, DHHS. 2003.https://ctep.cancer.gov/protocoldevelopment/electronic_applications/docs/ctcaev3.pdfAugust
9–2006
|
|
13
|
Osoba D, Rodrigues G, Myles J, Zee B and
Pater J: Interpreting the significance of changes in health-related
quality-of-life scores. J Clin Oncol. 16:139–144. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Giesinger JM, Kieffer JM, Fayers PM,
Groenvold M, Petersen MA, Scott NW, Sprangers MA, Velikova G and
Aaronson NK; EORTC Quality of Life Group, : Replication and
validation of higher order models demonstrated that a summary score
for the EORTC QLQ-C30 is robust. J Clin Epidemiol. 69:79–88. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Schumacher J, Klaiberg A and Brähler E:
Diagnostische Verfahren zu Lebensqualität und Wohlbefinden. 1st.
Göttingen, Hogrefe: Verlag für Psychologie; pp. 9–24. 2003
|
|
16
|
Taphoorn MJ, Sizoo EM and Bottomley A:
Review on quality of life issues in patients with primary brain
tumors. Oncologist. 15:618–626. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Carr AJ, Gibson B and Robinson PG:
Measuring quality of life: Is quality of life determined by
expectations or experience? BMJ. 322:1240–1243. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Okita Y, Narita Y, Miyahara R, Miyakita Y,
Ohno M and Shibui S: Health-related quality of life in long-term
survivors with Grade II gliomas: The contribution of disease
recurrence and Karnofsky Performance Status. Jpn J Clin Oncol.
45:906–913. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Henzel M, Fokas E, Sitter H, Wittig A and
Engenhart-Cabillic R: Quality of life after stereotactic
radiotherapy for meningioma: A prospective non-randomized study. J
Neurooncol. 113:135–141. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Aprile I, Chiesa S, Padua L, Di Blasi C,
Arezzo MF, Valentini V, DiStasio E and Balducci M: Occurrence and
predictors of the fatigue in high-grade glioma patients. Neurol
Sci. 36:1363–1369. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sehlen S, Hollenhorst H, Schymura B,
Herschbach P, Aydemir U, Firsching M and Dühmke E: Psychosocial
stress in cancer patients during and after radiotherapy.
Strahlenther Onkol. 179:175–180. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lucchiari C, Botturi A, Silvani A,
Lamperti E, Gaviani P, Innocenti A, Finocchiaro CY, Masiero M and
Pravettoni G: Cognitive strategies and quality of life of patients
with high-grade glioma. Support Care Cancer. 23:3427–3435. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Mainio A, Tuunanen S, Hakko H, Niemelä A,
Koivukangas J and Räsänen P: Decreased quality of life and
depression as predictors for shorter survival among patients with
low-grade gliomas: A follow-up from 1990 to 2003. Eur Arch
Psychiatry Clin Neurosci. 256:516–521. 2006. View Article : Google Scholar : PubMed/NCBI
|
